Design of polar XC 3 (X = P, As, Sb, Bi) monolayers with coupled bandgap, polarization, and optical responses
RSC Advances · 2026 · 16 (25) · 22564-22571
DOI: 10.1039/d6ra00272b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Wenxiao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Physics and Electronic Engineering, Center for Computational Sciences, Sichuan Normal University Chengdu 610068 China fubotao2008@gmail.co…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Sichuan Normal University.
Abstract (Originalsprache)
Bandgap engineering and polarization control in graphene-based systems are crucial for developing high-performance two-dimensional (2D) semiconductors.
Autor:innen und Institutionen
- College of Physics and Electronic Engineering, Center for Computational Sciences, Sichuan Normal University Chengdu 610068 China fubotao2008@gmail.com.
- College of Physics and Electronic Engineering, Sichuan Normal University Chengdu 610068 China changjing0394@163.com.
ORCID-Profile: Jing Chang, Botao Fu
Förderung
- National Natural Science Foundation of China
- Sichuan Normal University
Zitieren
APA
Li, W., Shi, J., Chang, J., & Fu, B. (2026). Design of polar XC 3 (X = P, As, Sb, Bi) monolayers with coupled bandgap, polarization, and optical responses. RSC Advances, 16(25), 22564-22571. https://doi.org/10.1039/d6ra00272b
Vancouver
Li W, Shi J, Chang J, Fu B. Design of polar XC 3 (X = P, As, Sb, Bi) monolayers with coupled bandgap, polarization, and optical responses. RSC Advances. 2026;16(25):22564-22571. doi:10.1039/d6ra00272b
BibTeX
@article{Li2026,
author = {Li, Wenxiao and Shi, Junlan and Chang, Jing and Fu, Botao},
title = {Design of polar XC 3 (X = P, As, Sb, Bi) monolayers with coupled bandgap, polarization, and optical responses},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {25},
pages = {22564--22571},
doi = {10.1039/d6ra00272b}
}
EUVIMED